AAAAAA
Results:
1-16
|
Results: 16
Authors:
MULLER MJ
ROSSBACH W
DANNIGKEIT P
MULLERSIECHENEDER F
SZEGEDI A
WETZEL H
Citation: Mj. Muller et al., EVALUATION OF STANDARDIZED RATER TRAINING FOR THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS), Schizophrenia research, 32(3), 1998, pp. 151-160
Authors:
MULLERSIECHENEDER F
MULLER MJ
HILLERT A
SZEGEDI A
WETZEL H
BENKERT O
Citation: F. Mullersiecheneder et al., RISPERIDONE VERSUS HALOPERIDOL AND AMITRIPTYLINE IN THE TREATMENT OF PATIENTS WITH A COMBINED PSYCHOTIC AND DEPRESSIVE SYNDROME, Journal of clinical psychopharmacology, 18(2), 1998, pp. 111-120
Authors:
WETZEL H
ANGHELESCU I
SZEGEDI A
WIESNER J
WEIGMANN H
HARTTER S
HIEMKE C
Citation: H. Wetzel et al., PHARMACOKINETIC INTERACTIONS OF CLOZAPINE WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS - DIFFERENTIAL-EFFECTS OF FLUVOXAMINE AND PAROXETINEIN A PROSPECTIVE-STUDY, Journal of clinical psychopharmacology, 18(1), 1998, pp. 2-9
Authors:
SZEGEDI A
WETZEL H
ANGERSBACH D
DUNBAR GC
SCHWARZE H
PHILIPP M
BENKERT O
Citation: A. Szegedi et al., A DOUBLE-BLIND-STUDY COMPARING PAROXETINE AND MAPROTILINE IN DEPRESSED OUTPATIENTS, Pharmacopsychiatry, 30(3), 1997, pp. 97-105
Authors:
PAULY T
SZEGEDI A
DAHMEN N
BOL GF
FERDINAND K
WETZEL H
HIEMKE C
Citation: T. Pauly et al., BLOOD ETHANOL LEVEL AND ADENYLYL-CYCLASE ACTIVITY IN LYMPHOCYTES OF ACTIVELY DRINKING ALCOHOLICS, European journal of cell biology, 72, 1997, pp. 303-303
Authors:
SZEGEDI A
WETZEL H
ANGERSBACH D
PHILIPP M
BENKERT O
Citation: A. Szegedi et al., RESPONSE TO TREATMENT IN MINOR AND MAJOR DEPRESSION - RESULTS OF A DOUBLE-BLIND COMPARATIVE-STUDY WITH PAROXETINE AND MAPROTILINE, Journal of affective disorders, 45(3), 1997, pp. 167-178
Authors:
SZEGEDI A
MESZAROS C
BAKOS B
HUNYADI J
SEMSEI I
Citation: A. Szegedi et al., EXAMINATION OF THE EXPRESSIONS OF LA AND RO ANTIGENS IN HUMAN KERATINOCYTES, Journal of investigative dermatology, 109(3), 1997, pp. 421-421
Authors:
BENKERT O
SZEGEDI A
WETZEL H
STAAB HJ
MEISTER W
PHILIPP M
Citation: O. Benkert et al., DOSE-ESCALATION VS CONTINUED DOSES OF PAROXETINE AND MAPROTILINE - A PROSPECTIVE-STUDY IN DEPRESSED OUT-PATIENTS WITH INADEQUATE TREATMENT RESPONSE, Acta psychiatrica Scandinavica, 95(4), 1997, pp. 288-296
Authors:
BENKERT O
SZEGEDI A
WETZEL H
Citation: O. Benkert et al., MINIMUM EFFECTIVE DOSE FOR ANTIDEPRESSANTS - AN OBLIGATORY REQUIREMENT FOR ANTIDEPRESSANT DRUG-EVALUATION, International clinical psychopharmacology, 11(3), 1996, pp. 177-185
Authors:
SZEGEDI A
CZIRJAK L
Citation: A. Szegedi et L. Czirjak, DETECTION OF ANTI-FC-GAMMA-R ANTIBODIES AND DIFFERENT CYTOKINES IN SERA FROM PATIENTS WITH SYSTEMIC-SCLEROSIS, Journal of the American Academy of Dermatology, 35(1), 1996, pp. 134-134
Authors:
SZEGEDI A
WETZEL H
LEAL M
HARTTER S
HIEMKE C
Citation: A. Szegedi et al., COMBINATION TREATMENT WITH CLOMIPRAMINE AND FLUVOXAMINE - DRUG-MONITORING, SAFETY, AND TOLERABILITY DATA, The Journal of clinical psychiatry, 57(6), 1996, pp. 257-264
Authors:
SZEGEDI A
CZIRJAK L
UNKELESS JC
BOROS P
Citation: A. Szegedi et al., SERUM CYTOKINE AND ANTI-FC-GAMMA-R AUTOANTIBODY MEASUREMENTS IN PATIENTS WITH SYSTEMIC-SCLEROSIS, Acta dermato-venereologica, 76(1), 1996, pp. 21-23
Authors:
WETZEL H
SZEGEDI A
HAIN C
WIESNER J
SCHLEGEL S
BENKERT O
Citation: H. Wetzel et al., SEROQUEL (ICI-204-636), A PUTATIVE ATYPICAL ANTIPSYCHOTIC, IN SCHIZOPHRENIA WITH POSITIVE SYMPTOMATOLOGY - RESULTS OF AN OPEN CLINICAL-TRIAL AND CHANGES OF NEUROENDOCRINOLOGICAL AND EEG PARAMETERS, Psychopharmacology, 119(2), 1995, pp. 231-238
Authors:
SZEGEDI A
WIESNER J
HIEMKE C
Citation: A. Szegedi et al., IMPROVED EFFICACY AND FEWER SIDE-EFFECTS UNDER CLOZAPINE TREATMENT AFTER ADDITION OF FLUVOXAMINE, Journal of clinical psychopharmacology, 15(2), 1995, pp. 141-143
Authors:
HARTTER S
HERMES B
SZEGEDI A
HIEMKE C
Citation: S. Hartter et al., AUTOMATED-DETERMINATION OF PAROXETINE AND ITS MAIN METABOLITE BY COLUMN-SWITCHING AND ONLINE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Therapeutic drug monitoring, 16(4), 1994, pp. 400-406
Authors:
BENKERT O
WETZEL H
SZEGEDI A
Citation: O. Benkert et al., SEROTONIN DYSFUNCTION SYNDROMES - A FUNCTIONAL COMMON DENOMINATOR FORCLASSIFICATION OF DEPRESSION, ANXIETY, AND OBSESSIVE-COMPULSIVE DISORDER, International clinical psychopharmacology, 8, 1993, pp. 3-14
Risultati:
1-16
|